カテゴリ： FactMR, 世界, 医療/バイオ

遺伝子検査サービスのグローバル市場2023～2033：出生前検査、新生児検診、予測＆予兆検査、ファーマコゲノム検査、その他

■ 英語タイトル：Genetic Testing Services Market Analysis By Test Type (Prenatal Testing, New Born Screening, Predictive and Presymptomatic Testing, Pharmacogenomic Testing), By Application (Oncology, Infectious Diseases, Autoimmune Diseases), By Service Provider (Hospital-based Laboratories, Diagnostic Laboratories, Specialty Clinics) & Region – Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23AP091）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23AP091
■ 発行日：2023年1月25日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[遺伝子検査サービスのグローバル市場2023～2033：出生前検査、新生児検診、予測＆予兆検査、ファーマコゲノム検査、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社による最新調査レポートでは、世界の遺伝子検査サービス市場について2023年度から2033年度までの10年間にわたる市場規模予測を掲載しています。当書では、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、検査タイプ別（出生前検査、新生児検診、予測＆予兆検査、ファーマコゲノム検査、その他）分析、サービスプロバイダー別（病院内ラボ、診断ラボ、専門クリニック、その他）分析、用途別（がん、感染症、自己免疫疾患、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析などの項目を掲載しています。なお、当市場の主要企業には、Laboratory Corporation of America Holdings、Quest Diagnostics Incorporated、Genomic Health, Inc.などが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・世界の遺伝子検査サービス市場規模：検査タイプ別
　- 出生前検査の市場規模
　- 新生児検診の市場規模
　- 予測＆予兆検査の市場規模
　- ファーマコゲノム検査の市場規模
　- その他検査タイプの市場規模
・世界の遺伝子検査サービス市場規模：サービスプロバイダー別
　- 病院内ラボの市場規模
　- 診断ラボの市場規模
　- 専門クリニックの市場規模
　- その他サービスプロバイダーの市場規模
・世界の遺伝子検査サービス市場規模：用途別
　- がんにおける市場規模
　- 感染症における市場規模
　- 自己免疫疾患における市場規模
　- その他用途における市場規模
・世界の遺伝子検査サービス市場規模：地域別
　- 北米の遺伝子検査サービス市場規模
　- ヨーロッパの遺伝子検査サービス市場規模
　- アジア太平洋の遺伝子検査サービス市場規模
　- 中南米の遺伝子検査サービス市場規模
　- 中東/アフリカの遺伝子検査サービス市場規模
・企業情報

本書は、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などのエッセンスを含む企業情報を含んでいます。企業のプレゼンスは、すべての著名な市場参入者についてマッピングされ、マトリックスを通して提示されます。したがって、購読者に実用的なインサイトを提供し、熟考して市場状況などを提示し、遺伝子検査サービスにおける競争レベルを予想するのに有効です。

Genetic Testing Services Market – Scope of Report

A recent study by Fact.MR on the genetic testing services market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering genetic testing services.

The study also provides the dynamics responsible for influencing the future status of the genetic testing services market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the genetic testing services market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of genetic testing services across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of genetic testing services during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for genetic testing services are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global genetic testing services market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the genetic testing services market during the forecast period.

Country-specific valuation on demand for genetic testing services has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of genetic testing services, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering genetic testing services has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the genetic testing services domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033

    3.2. Global Market: Market Snapshot

4. Market Overview

    4.1. Global Market Overview

    4.2. Global Market Key Industry Developments

    4.3. Key Industry Events

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Market Revenue Projections (US$ Mn), 2023–2033

    5.7. Market: Mergers & Acquisitions

    5.8. Heat Map Analysis – Company

6. Global Market Analysis, by Test Type

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Market Size and Forecast, by Test Type

        6.3.1. Prenatal Testing Services

        6.3.2. New Born Screening

        6.3.3. Predictive and Presymptomatic Testing

        6.3.4. Pharmacogenomic Testing

        6.3.5. Others

    6.4. Global Market Analysis, by Test Type

    6.5. Global Market Attractiveness Analysis, by Test Type

7. Global Market Analysis, by Service Providers

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Market Size and Forecast, by Service Providers

        7.3.1. Hospital Based Laboratories

        7.3.2. Diagnostic laboratories

        7.3.3. Specialty Clinics

        7.3.4. Others

    7.4. Global Market Analysis, by Service Providers

    7.5. Global Market Attractiveness Analysis, by Service Providers

8. Global Market Analysis, by Applications

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Market Size and Forecast, by Applications

        8.3.1. Oncology

        8.3.2. Infectious Diseases

        8.3.3. Autoimmune Diseases

        8.3.4. Others

    8.4. Global Market Analysis, by Applications

    8.5. Global Market Attractiveness Analysis, by Applications

9. Global Market Analysis, by Region

    9.1. Introduction

    9.2. Key Insights

    9.3. Global Market Size and Forecast , by Region, 2023–2033

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

    9.4. Global Market Analysis, by Region

    9.5. Global Market Attractiveness Analysis, by Region

10. North America Market Analysis

    10.1. North America Market Key Findings

    10.2. North America Market Overview

    10.3. North America Market Size and Forecast, by Test Type

        10.3.1. Prenatal Testing Services

        10.3.2. New Born Screening

        10.3.3. Predictive and Presymptomatic Testing

        10.3.4. Pharmacogenomic Testing

        10.3.5. Others

        10.3.6. North America Market Analysis, by Test Type

    10.4. North America Market Size and Forecast, by Service Providers

        10.4.1. Hospital Based Laboratories

        10.4.2. Diagnostic laboratories

        10.4.3. Specialty Clinics

        10.4.4. Others

    10.5. North America Market Forecast, by Applications

        10.5.1. Oncology

        10.5.2. Infectious Diseases

        10.5.3. Autoimmune Diseases

        10.5.4. Others

    10.6. North America Market Forecast, by Country

        10.6.1. U.S.

        10.6.2. Canada

    10.7. North America Market Attractiveness Analysis

        10.7.1. By Test Type

        10.7.2. By Service Providers

        10.7.3. By Applications

        10.7.4. By Country

11. Europe Market Analysis

    11.1. Europe Market Key Findings

    11.2. Europe Market Overview

    11.3. Europe Market Size and Forecast, by Test Type

        11.3.1. Prenatal Testing Services

        11.3.2. New Born Screening

        11.3.3. Predictive and Presymptomatic Testing

        11.3.4. Pharmacogenomic Testing

        11.3.5. Others

    11.4. Europe Market Size and Forecast, by Service Providers

        11.4.1. Hospital Based Laboratories

        11.4.2. Diagnostic laboratories

        11.4.3. Specialty Clinics

        11.4.4. Others

    11.5. Europe Market Forecast, by Applications

        11.5.1. Oncology

        11.5.2. Infectious Diseases

        11.5.3. Autoimmune Diseases

        11.5.4. Others

    11.6. Europe Market Forecast, by Country

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Spain

        11.6.5. Italy

        11.6.6. Rest of Europe

    11.7. Europe Market Attractiveness Analysis

        11.7.1. By Test Type

        11.7.2. By Service Providers

        11.7.3. By Applications

        11.7.4. By Country

12. Asia Pacific Market Analysis

    12.1. Asia Pacific Market Key Findings

    12.2. Asia Pacific Market Overview

    12.3. Asia Pacific Cytometry Market Size and Forecast, by Test Type

        12.3.1. Prenatal Testing Services

        12.3.2. New Born Screening

        12.3.3. Predictive and Presymptomatic Testing

        12.3.4. Pharmacogenomic Testing

        12.3.5. Others

    12.4. Asia Pacific Market Size and Forecast, by Service Providers

        12.4.1. Hospital Based Laboratories

        12.4.2. Diagnostic laboratories

        12.4.3. Specialty Clinics

        12.4.4. Others

    12.5. Asia Pacific Market Forecast, by Applications

        12.5.1. Oncology

        12.5.2. Infectious Diseases

        12.5.3. Autoimmune Diseases

        12.5.4. Others

    12.6. Asia Pacific Market Forecast, by Country

        12.6.1. China

        12.6.2. India

        12.6.3. Japan

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Asia Pacific Market Attractiveness Analysis

        12.7.1. By Test Type

        12.7.2. By Service Providers

        12.7.3. By Applications

        12.7.4. By Country

13. Latin America Market Analysis

    13.1. Latin America Market Key Findings

    13.2. Latin America Market Overview

    13.3. Latin America Cytometry Market Size and Forecast, by Test Type

        13.3.1. Prenatal Testing Services

        13.3.2. New Born Screening

        13.3.3. Predictive and Presymptomatic Testing

        13.3.4. Pharmacogenomic Testing

        13.3.5. Others

    13.4. Latin America Market Size and Forecast, by Service Providers

        13.4.1. Hospital Based Laboratories

        13.4.2. Diagnostic laboratories

        13.4.3. Specialty Clinics

        13.4.4. Others

    13.5. Latin America Market Forecast, by Country

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Market Forecast, by Applications

        13.6.1. Oncology

        13.6.2. Infectious Diseases

        13.6.3. Autoimmune Diseases

        13.6.4. Others

    13.7. Latin America Market Attractiveness Analysis

        13.7.1. By Test Type

        13.7.2. By Service Providers

        13.7.3. By Applications

        13.7.4. By Country

14. Middle East & Africa Market Analysis

    14.1. Middle East & Africa Market Key Findings

    14.2. Middle East & Africa Market Overview

    14.3. Middle East & Africa Cytometry Market Size and Forecast, by Test Type

        14.3.1. Prenatal Testing Services

        14.3.2. New Born Screening

        14.3.3. Predictive and Presymptomatic Testing

        14.3.4. Pharmacogenomic Testing

        14.3.5. Others

    14.4. Middle East & Africa Market Size and Forecast, by Service Providers

        14.4.1. Hospital Based Laboratories

        14.4.2. Diagnostic laboratories

        14.4.3. Specialty Clinics

        14.4.4. Others

    14.5. Middle East & Africa Market Forecast, by Applications

        14.5.1. Oncology

        14.5.2. Infectious Diseases

        14.5.3. Autoimmune Diseases

        14.5.4. Others

    14.6. Middle East & Africa Market Size and Forecast, by Country

        14.6.1. GCC Countries

        14.6.2. Israel

        14.6.3. South Africa

        14.6.4. Rest of Middle East & Africa

    14.7. Middle East Market Attractiveness Analysis

        14.7.1. By Test Type

        14.7.2. By Service Providers

        14.7.3. By Applications

        14.7.4. By Country

15. Competition Landscape

    15.1. Global Market Share Analysis, by Company (2022)

    15.2. Company Profiles

        15.2.1. Laboratory Corporation of America Holdings

            15.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.1.2. Financials

            15.2.1.3. Recent Developments

            15.2.1.4. Strategy

        15.2.2. Quest Diagnostics Incorporated

            15.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.2.2. Financials

            15.2.2.3. Recent Developments

            15.2.2.4. Strategy

        15.2.3. Genomic Health, Inc.

            15.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.3.2. Financials

            15.2.3.3. Recent Developments

            15.2.3.4. Strategy

        15.2.4. NeoGenomics Laboratories, Inc.

            15.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.4.2. Financials

            15.2.4.3. Recent Developments

            15.2.4.4. Strategy

        15.2.5. Eurofins Scientific

            15.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.5.2. Financials

            15.2.5.3. Recent Developments

            15.2.5.4. Strategy

        15.2.6. Ambry Genetics

            15.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.6.2. Financials

            15.2.6.3. Recent Developments

            15.2.6.4. Strategy

        15.2.7. F. Hoffmann-La Roche Ltd

            15.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.7.2. Financials

            15.2.7.3. Recent Developments

            15.2.7.4. Strategy

        15.2.8. Illumina, Inc

            15.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.8.2. Financials

            15.2.8.3. Recent Developments

            15.2.8.4. Strategy

        15.2.9. CENTOGENE AG

            15.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.9.2. Financials

            15.2.9.3. Recent Developments

            15.2.9.4. Strategy

        15.2.10. 23andMe, Inc.

            15.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.10.2. Financials

            15.2.10.3. Recent Developments

            15.2.10.4. Strategy

Table 01: Global Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 02: Global Market Value (US$ Mn) Forecast, by Service Provider, 2023–2033

Table 03: Global Market Value (US$ Mn) Forecast, by Applications, 2023–2033

Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 05: North America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 06: North America Market Value (US$ Mn) Forecast, by Service Providers,

Table 07: North America Market Value (US$ Mn) Forecast, by Applications,

Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 09: Europe Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 10: Europe Market Value (US$ Mn) Forecast, by Service Providers,

Table 11: Europe Market Value (US$ Mn) Forecast, by Applications,

Table 12: Europe Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 13: Asia Pacific Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Service Providers,

Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Applications,

Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 17: Latin America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 18: Latin America Market Value (US$ Mn) Forecast, by Service Providers,

Table 19: Latin America Market Value (US$ Mn) Forecast, by Applications,

Table 20: Latin America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Providers,

Table 23: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Applications

Table 24: Middle East & Africa Market Value (US$ Mn) Forecast, by Country, 2023–2033

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 遺伝子検査のグローバル市場：予測検査＆予兆検査、キャリア検査、出生前＆新生児検査、診断検査、その他
  • In Vivo毒物学の世界市場2023～2033：製品別、検査別、検査施設別、毒性エンドポイント別、エンドユーザー別、地域別
  • 非破壊検査のグローバル市場（~2033）：サービス、機器
  • 防塵剤のグローバル市場2023～2033（~2033）：湿式防塵剤、乾式防塵剤
  • メラノーマ癌診断のグローバル市場2023～2033：蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23AP091 )"遺伝子検査サービスのグローバル市場2023～2033：出生前検査、新生児検診、予測＆予兆検査、ファーマコゲノム検査、その他" (英文：Genetic Testing Services Market Analysis By Test Type (Prenatal Testing, New Born Screening, Predictive and Presymptomatic Testing, Pharmacogenomic Testing), By Application (Oncology, Infectious Diseases, Autoimmune Diseases), By Service Provider (Hospital-based Laboratories, Diagnostic Laboratories, Specialty Clinics) & Region – Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。